Financial Snapshot

Revenue
$3.011M
TTM
Gross Margin
69.56%
TTM
Net Earnings
-$771.9K
TTM
Current Assets
Q3 2024
Current Liabilities
Q3 2024
Current Ratio
104.04%
Q3 2024
Total Assets
Q3 2024
Total Liabilities
Book Value
Cash
Q3 2024
P/E
-10.03
Nov 29, 2024 EST
Free Cash Flow
$74.34K
TTM

Revenues

Revenues

Loading...

Revenue YoY Change

Loading...

Revenues

Concept 2023 2022 2021 2020 2019 2018 2017 2016
Revenue $2.486M $2.251M $1.466M $1.277M $748.4K $67.13K $128.1K $162.8K
YoY Change 10.41% 53.6% 14.82% 70.58% 1014.82% -47.6% -21.28%

Expenses

Cost Of Revenues

Loading...

Gross Profit

Loading...

Gross Profit Margin

Loading...

Gross Profit

Concept 2023 2022 2021 2020 2019 2018 2017 2016
Revenue $2.486M $2.251M $1.466M $1.277M $748.4K $67.13K $128.1K $162.8K
Cost Of Revenue $864.1K $880.0K $346.2K $1.855M $524.5K $28.59K $43.65K $26.93K
Gross Profit $1.622M $1.372M $1.120M -$578.4K $223.9K $38.54K $84.46K $135.8K
Gross Profit Margin 65.24% 60.92% 76.38% -45.31% 29.92% 57.41% 65.93% 83.45%

Selling, General & Admin Expense

Loading...

Research & Development

Loading...

Depreciation, Depletion & Amortization

Loading...

SGA Expense to Gross Profit Ratio

Loading...

R&D To Gross Profit Ratio

Loading...

DDA To Gross Profit Ratio

Loading...

Operating Expenses Total

Loading...

Operating Profits/Loss

Loading...

Operational Expenses

Concept 2023 2022 2021 2020 2019 2018 2017 2016
Selling, General & Admin $3.866M $2.283M $2.584M $1.475M $1.164M $546.0K $951.9K $961.6K
YoY Change 69.32% -11.65% 75.22% 26.74% 113.13% -42.64% -1.0%
% of Gross Profit 238.35% 166.47% 230.82% 519.79% 1416.79% 1127.07% 707.98%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $2.200K $880.00 $5.100K $9.050K $8.530K $8.330K $3.090K $1.330K
YoY Change 150.0% -82.75% -43.65% 6.1% 2.4% 169.58% 132.33%
% of Gross Profit 0.14% 0.06% 0.46% 3.81% 21.61% 3.66% 0.98%
Operating Expenses $3.866M $2.283M $2.584M $1.475M $1.164M $546.0K $951.9K $961.6K
YoY Change 69.32% -11.65% 75.22% 26.74% 113.13% -42.64% -1.0%
Operating Profit -$2.244M -$911.6K -$1.465M -$2.053M -$939.9K -$507.5K -$867.5K -$825.8K
YoY Change 146.15% -37.76% -28.67% 118.47% 85.2% -41.5% 5.05% 12.97%

Interest Expenses

Loading...

Interest Expenses To Operating Income %

Loading...

Other Expense/Income

Loading...

Interest & Other Expense/Income

Concept 2023 2022 2021 2020 2019 2018 2017 2016
Interest Expense -$229.1K -$74.17K -$137.8K $980.3K $1.520M -$1.453M -$2.525M -$2.497M
YoY Change 208.87% -46.17% -114.05% -35.49% -204.61% -42.47% 1.11%
% of Operating Profit
Other Income/Expense, Net -$229.1K -$71.53K -$97.95K $0.00
YoY Change 220.26% -26.97%

Income/Loss

Pretax Income

Loading...

Income Tax

Loading...

Net Profits/Loss

Loading...

Pretax Income YoY Change

Loading...

Income Tax Rate

Loading...

Net Profits/Loss YoY Change

Loading...

Basic EPS

Loading...

Net Income To Revenue Ratio

Loading...

Pretax & Net Income

Concept 2023 2022 2021 2020 2019 2018 2017 2016
Pretax Income -$2.473M -$983.1K -$1.987M -$2.576M $632.8K -$3.323M -$3.562M -$3.371M
YoY Change 151.54% -50.53% -22.87% -507.15% -119.04% -6.7% 5.67%
Income Tax $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
% Of Pretax Income 0.0%
Net Earnings -$2.473M -$983.1K -$1.987M -$2.576M $632.8K -$3.330M -$3.562M -$3.371M
YoY Change 151.54% -50.53% -22.87% -507.15% -119.01% -6.53% 5.67%
Net Earnings / Revenue -99.48% -43.67% -135.57% -201.82% 84.55% -4959.81% -2780.49% -2071.24%
Basic Earnings Per Share
Diluted Earnings Per Share -$0.85 $0.00 -$6.225K -$10.86K $5.721K -$1.212M -$15.82M -$53.73M

Assets & Liabilities

Cash & Short-Term Investments

Loading...

Cash & Equivalents

Loading...

Cash To Operating Expenses Ratio

Loading...

Inventory

Loading...

Receivables

Loading...

Total Short-Term Assets

Loading...

Property, Plant And Equipment

Loading...

Long-Term Investments

Loading...

Total Long-Term Assets

Loading...

Total Assets

Loading...

Net Income To Total Assets Percentage

Loading...

Accounts Payable

Loading...

Short-Term Debt

Loading...

Long Term Debt Due

Loading...

Total Short-Term Liabilities

Loading...

Long-Term Debt

Loading...

Other Long-Term Liabilities

Loading...

Total Long-Term Liabilities

Loading...

Total Liabilities

Loading...

Short-Term To Long-Term Debt Ratio

Loading...

Short-Term Assets To Debt Ratio

Loading...

Long-Term Debt To Net Income Ratio

Loading...

Assets & Liabilities

Concept 2023 2022 2021 2020 2019 2018 2017 2016
Cash & Short-Term Investments $19.44K $65.65K $222.1K $59.20K $133.5K $490.00 $81.65K $24.10K
YoY Change -70.39% -70.44% 275.17% -55.64% 27134.69% -99.4% 238.8%
Cash & Equivalents
Short-Term Investments
Other Short-Term Assets $223.5K $0.00 $0.00 $7.430K
YoY Change -100.0%
Inventory $1.626M $1.819M $1.958M $2.418M $3.081M $500.00 $48.47K
Prepaid Expenses
Receivables $30.44K $105.8K $133.3K $13.27K $26.47K $16.00K $66.00K
Other Receivables $0.00 $0.00 $0.00 $0.00 $0.00 $80.89K $46.30K
Total Short-Term Assets $1.900M $1.991M $2.313M $2.490M $3.241M $5.750K $227.0K $143.8K
YoY Change -4.57% -13.95% -7.1% -23.17% 56266.61% -97.47% 57.83%
Property, Plant & Equipment $3.310K $5.500K $1.040K $6.140K $15.18K $730.00 $1.650K $1.190K
YoY Change -39.82% 428.85% -83.06% -59.55% 1979.45% -55.76% 38.66%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $16.89K $69.90K $0.00 $0.00
YoY Change -75.84%
Total Long-Term Assets $735.3K $790.6K $716.2K $625.3K $208.5K $80.02K $895.7K $2.350K
YoY Change -6.99% 10.38% 14.54% 199.96% 160.5% -91.07% 38016.6%
Total Assets $2.635M $2.781M $3.030M $3.115M $3.450M $85.77K $1.123M $146.2K
YoY Change
Accounts Payable $116.8K $91.32K $37.27K $64.84K $21.13K $72.34K $71.36K $29.91K
YoY Change 27.95% 145.02% -42.52% 206.86% -70.79% 1.37% 138.58%
Accrued Expenses $347.2K $115.9K $86.43K $11.95K $594.5K $85.65K $25.22K $16.64K
YoY Change 199.42% 34.14% 623.26% -97.99% 594.06% 239.61% 51.56%
Deferred Revenue
YoY Change
Short-Term Debt $1.053M $593.5K $342.6K $177.6K $2.639M $778.7K $382.7K $420.1K
YoY Change 77.43% 73.23% 92.89% -93.27% 238.93% 103.46% -8.9%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.671M $902.8K $558.8K $261.6K $4.315M $3.650M $2.302M $2.506M
YoY Change 85.12% 61.55% 113.62% -93.94% 18.22% 58.57% -8.13%
Long-Term Debt $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $9.220K $0.00 $0.00
YoY Change
Total Long-Term Liabilities $9.220K $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
YoY Change
Total Liabilities $1.680M $902.8K $558.8K $261.6K $4.315M $3.650M $2.302M $2.506M
YoY Change 86.14% 61.55% 113.62% -93.94% 18.22% 58.57% -8.13%

Ownership

Basic Shares Outstanding

Loading...

Diluted Shares Outstanding

Loading...

Preferred Stock

Loading...

Treasury Stock Shares

Loading...

Stock Issuance & Repurchase

Loading...

Ownership Data

Concept 2023 2022 2021 2020 2019 2018 2017 2016
Basic Shares Outstanding
Diluted Shares Outstanding
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Loading...

Book Value

Loading...

Free Cash Flow

Loading...

Free Cash Flow YoY

Loading...

Free Cash Flow Margin

Loading...

Dividends

Dividends

Loading...

Stock Price

Loading...
Market Cap: $7.7426 Million

About HEALTHY EXTRACTS INC.

Healthy Extracts, Inc. operates as a platform for developing or acquiring science-forward, clinically proven and plant-based proprietary products. The company is headquartered in Henderson, Nevada. The company went IPO on 2015-10-13. The Company, through BergaMet NA, LLC and Ultimate Brain Nutrients, LLC markets and sells health supplemental products. Its segments include Health Supplements and Corporate. The company develops, manufactures, and distributes bergamot-based products (BPF) in tablet and capsule under BergaMet Pro+, BergaMet Mega+O, BergaMet HERHEART, BergaMet Cholesterol Command, BergaMet SPORTSHEART and BergaMet CLINICAL IMMUNE. BPF Bergamet products are distributed in North America that contain Citrus Bergamot SuperFruit. Its BergaMet products are certified organic, vegan friendly, non-GMO and gluten-free. Its UBN develops plant-based health technology neuro-products to improve brain health, including memory, cognition, focus and neuro-energy. Its brain health products are sold under various product labels, including UBN ACTIVATE, UBN RELIEF, and Brain Activate-Gel.

Industry: Medicinal Chemicals & Botanical Products Peers: